- Investing Ideas
- /
- Swedish Fast Growing Stocks With High Insider Ownership
Swedish Fast Growing Stocks With High Insider Ownership
Results
90
0 new
Companies with strong growth potential, backed by optimistic outlooks both from analysts and management.
90 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
KEBNI B | SEK 1.49 | -1.1% | 3.6% | SEK 404.0m | SEK 2.20 | PS4.4x | E90.4% | n/a | Tech | ||
CALTX | SEK 206.20 | 0% | 110.9% | SEK 11.1b | SEK 221.25 | PS8.5x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
YUBICO | SEK 270.50 | 0.9% | 170.8% | SEK 23.3b | SEK 267.50 | PE140.7x | E43.8% | n/a | Software | ||
YIELD | SEK 2.39 | 0.8% | -66.7% | SEK 136.9m | SEK 9.00 | PB1.6x | E103.4% | n/a | Diversified Financials | ||
MAGLE | SEK 42.00 | -3.2% | 21.4% | SEK 453.6m | SEK 50.00 | PE58.9x | E72.2% | n/a | Pharmaceuticals & Biotech | ||
CTT | SEK 274.00 | -4.2% | 29.2% | SEK 3.4b | n/a | PE33.7x | E24.8% | 2.0% | Capital Goods | ||
BIOA B | SEK 160.50 | -31.4% | -46.4% | SEK 14.2b | SEK 336.40 | PS56.2x | E103.4% | 0% | Pharmaceuticals & Biotech | ||
EDYOU | SEK 1.32 | 37.5% | 1.1% | SEK 49.2m | n/a | PS1.5x | E63.1% | n/a | Media | ||
BIOVIC B | SEK 2.96 | 11.9% | -68.8% | SEK 248.8m | SEK 7.90 | PS34.1x | E73.8% | n/a | Pharmaceuticals & Biotech | ||
INCOAX | SEK 2.36 | 2.6% | -21.6% | SEK 255.3m | SEK 3.65 | PS2.6x | E104.9% | n/a | Tech | ||
CRAD B | SEK 43.40 | -4.0% | 56.1% | SEK 1.5b | SEK 57.00 | PE27.3x | E33.9% | n/a | Healthcare | ||
ORGC | SEK 3.44 | -3.1% | -21.8% | SEK 337.5m | SEK 3.00 | PS2.4x | E109.0% | n/a | Materials | ||
FLEXQ | SEK 11.40 | 12.9% | -57.9% | SEK 152.8m | SEK 25.00 | PS1.2x | E111.9% | n/a | Capital Goods | ||
ORT B | SEK 10.10 | 11.2% | 35.8% | SEK 374.5m | SEK 19.50 | PS6x | E91.6% | n/a | Healthcare | ||
CTM | SEK 6.63 | -0.9% | -72.9% | SEK 501.6m | SEK 29.70 | PB0.3x | E115.4% | 0% | Media | ||
KLAR | SEK 0.32 | -16.6% | -47.7% | SEK 41.0m | SEK 1.00 | PB1.4x | E61.3% | n/a | Pharmaceuticals & Biotech | ||
EQT | SEK 346.90 | 3.1% | 45.8% | SEK 410.3b | SEK 366.15 | PE117.5x | E56.7% | 1.0% | Diversified Financials | ||
MIDS | SEK 1.39 | 8.1% | -40.8% | SEK 292.3m | SEK 2.80 | PS4.5x | E89.9% | n/a | Semiconductors | ||
4C | SEK 21.40 | 15.7% | -18.3% | SEK 751.8m | SEK 22.00 | PS2.6x | E108.0% | n/a | Software | ||
SENZA | SEK 7.15 | -0.7% | -31.9% | SEK 211.0m | SEK 16.50 | PS4.1x | E67.8% | n/a | Pharmaceuticals & Biotech | ||
TRUE B | SEK 33.86 | 1.3% | -15.4% | SEK 11.7b | SEK 54.83 | PE24.5x | E21.5% | 1.2% | Software | ||
NIUTEC | SEK 6.60 | -0.6% | -42.5% | SEK 133.2m | SEK 9.50 | PB1.6x | E94.1% | n/a | Capital Goods | ||
FNOX | SEK 66.04 | 1.5% | 4.2% | SEK 40.3b | SEK 73.00 | PE62x | E22.6% | 0.3% | Software | ||
EGTX | SEK 5.83 | -2.8% | 41.2% | SEK 1.7b | SEK 13.30 | PS27.1x | E98.6% | n/a | Pharmaceuticals & Biotech |